The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...

The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...

The government program, known as 340B, allows hospitals that care for many uninsured and low-income patients to purchase ...

What is it that the PBM industry doesn’t want you to know?” asked the CEO of the Florida Pharmacy Association.

The Maryland General Assembly appears to be on its way to expanding the authority of its Prescription Drug Affordability Board, empowering the first such entity in the nation to find ways to bring ...

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Ben Hargreaves speaks to an expert in the area to learn how ...

This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505(b)(2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...

The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...